A PVRI Symposium: Genetics-inspired Therapeutics for Pulmonary Hypertension (PH)

A PVRI Symposium: Genetics-inspired Therapeutics for Pulmonary Hypertension (PH) is organized by Pulmonary Vascular Research Institute (PVRI) and will be held on Jun 02, 2026 at Royal College of Physicians, London, England, United Kingdom.

Description:
Join us for this one-day Symposium to review our current understanding of the genetics of PH, the impact on therapeutic drug development and the potential to deliver further therapeutic gains.

Programme:
Genetic discovery has transformed how we understand PAH. This Symposium brings together global experts to examine what that means in practice – for biology, clinical trials, and future therapies.
Across the day, the programme will explore four core themes:

• 08:00 - 09:00: Registration and refreshments
• 09:00 - 10:05: Genetic insights into pulmonary vascular disease
• 10:05 - 10:45: Therapeutic agents targeting the TGF-?/BMP pathway – Part 1
• 10:45 - 11:15: Refreshment break
• 11:15 - 12:30: Therapeutic agents targeting the TGF-?/BMP pathway – Part 1
• 12:30 - 13:30: Buffet lunch
• 13:30 - 15:30: Therapeutic agents targeting the TGF-?/BMP pathway – Part 2
• 15:30 - 16:00: Refreshment break
• 16:00 - 17:00: Developing therapeutic agents to target other genetically validated pathways
• 17:00 - 18:30: Networking reception

The programme combines scientific depth with practical discussion, creating space for critical thinking, collaboration, and forward-looking debate.